Article
Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes.
The Journal of clinical investigation - 2 Jul 2018
Rodriguez-Muela Natalia, Parkhitko Andrey, Grass Tobias, Gibbs Rebecca M, Norabuena Erika M, Perrimon Norbert, Singh Rajat, Rubin Lee L
Abstract excerpt
Spinal muscular atrophy (SMA), a degenerative motor neuron (MN) disease, caused by loss of functional survival of motor neuron (SMN) protein due to SMN1 gene mutations, is a leading cause of infant mortality. Increasing SMN levels ameliorates the disease phenotype and is unanimously accepted as a therapeutic approach for patients with SMA. The ubiquitin/proteasome system is known to regulate SMN protein levels;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.